
Conference Coverage
about 2 hours ago
Optimizing Nonsurgical Management of Skin Tumors at Maui Derm 2026about 20 hours ago
New Dermatologic Therapies Make Waves at Maui Derm 2026Latest Content

Optimizing Nonsurgical Management of Skin Tumors at Maui Derm 2026

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

LLMs Help Complement Clinician Guidance for Patients After Mohs Surgery

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

New Dermatologic Therapies Make Waves at Maui Derm 2026
Shorts










Podcasts
Center on Health Equity & Access
All News

Experts raise concerns that CDC childhood immunization changes could reduce vaccine uptake and weaken trust in public health guidance.

This approval brings the total indications for daratumumab and hyaluronidase to 5 in newly diagnosed disease and its 12th overall.

Minnesota physicians warn ICE activity in hospitals and clinics is deterring care, undermining patient safety, and worsening health outcomes.

CMS’s 2027 proposed MA payment rate increase of .09% falls short of expectations, potentially increasing premiums and reducing benefits for seniors.

A letter from the guest editor introduces this year’s Health Information Technology issue, which explores 4 key themes driving health care’s digital transformation from basic automation to human-centered integration.

A Michigan-based deliberative study found strong public support for patient-informed artificial intelligence (AI) labeling in health care, emphasizing transparency, privacy, equity, and safety to build trust.

With the CDC’s decision to roll back recommendations to vaccinate for several conditions, questions have arisen as to what that may mean in the US.

Nearly two-thirds of hospitals using Epic have adopted ambient artificial intelligence (AI), with higher uptake among larger, not-for-profit hospitals and those with higher workload and stronger financial performance.

Almost half of the monthly-updated CDC databases had unexplained pauses in 2025, mostly affecting vaccination data, raising transparency and public health concerns.

ACE inhibitors may improve survival in IPF patients, highlighting potential repurposing of a common cardiovascular drug.
























